These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30052955)

  • 21. Role of laser atherectomy for the management of in-stent restenosis in the peripheral arteries.
    Jayasuriya S; Ward C; Mena-Hurtado C
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):339-45. PubMed ID: 24755702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease.
    Lichtenberg MK; Carr JG; Golzar JA
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):518-527. PubMed ID: 28382804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.
    Cassese S; Ndrepepa G; Kufner S; Byrne RA; Giacoppo D; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    EuroIntervention; 2017 Jul; 13(4):483-489. PubMed ID: 28169215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of in-stent restenosis with excimer laser coronary angioplasty: benefits over scoring balloon angioplasty alone.
    Hirose S; Ashikaga T; Hatano Y; Yoshikawa S; Sasaoka T; Maejima Y; Isobe M
    Lasers Med Sci; 2016 Nov; 31(8):1691-1696. PubMed ID: 27516177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-Year Freedom From Target-Lesion Revascularization Using Excimer Laser Ablation Therapy in the Treatment of In-Stent Restenosis of Femoropopliteal Arteries.
    Shammas NW; Shammas GA; Arikat L; Shammas AN; Darrow A; Banerjee A; Rudy B
    J Invasive Cardiol; 2017 Jun; 29(6):207-208. PubMed ID: 28570235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
    Barkat M; Torella F; Antoniou GA
    Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Femoropopliteal in-stent restenosis: current treatment strategies.
    Singh GD; Armstrong EJ; Laird JR
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):325-33. PubMed ID: 24755700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty.
    Adamian M; Colombo A; Briguori C; Nishida T; Marsico F; Di Mario C; Albiero R; Moussa I; Moses JW
    J Am Coll Cardiol; 2001 Sep; 38(3):672-9. PubMed ID: 11527615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment.
    Ishihara T; Dohi T; Nakamura D; Kikuchi A; Okamoto N; Mori N; Iida O; Tsujimura T; Mizote I; Higuchi Y; Yamada T; Nishino M; Mano T; Sakata Y;
    Int J Cardiol; 2021 Sep; 339():28-32. PubMed ID: 34265314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral artery disease: Laser light show--targeting in-stent restenosis in peripheral arteries with excimer laser atherectomy.
    Geach T
    Nat Rev Cardiol; 2015 Feb; 12(2):63. PubMed ID: 25560374
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Recurrent In-Stent Restenosis After Paclitaxel-Coated Balloon Angioplasty.
    Koiwaya H; Watanabe N; Kuriyama N; Nishino S; Ogata K; Kimura T; Nakama T; Matsuura H; Furugen M; Shibata Y
    Circ J; 2017 Aug; 81(9):1286-1292. PubMed ID: 28450676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-Analysis-Derived Benchmarks of Patency and Target Lesion Revascularization of Percutaneous Balloon Angioplasty from Prospective Clinical Trials of Symptomatic Femoropopliteal In-Stent Restenosis.
    Shammas NW; Jones-Miller S; Lemke J
    J Vasc Interv Radiol; 2016 Aug; 27(8):1195-203. PubMed ID: 27350033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.
    Shammas NW; Shammas GA; Banerjee S; Popma JJ; Mohammad A; Jerin M
    J Endovasc Ther; 2016 Apr; 23(2):339-46. PubMed ID: 26921281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH).
    Ott I; Cassese S; Groha P; Steppich B; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Hiendlmayer R; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    Circulation; 2017 Jun; 135(23):2218-2226. PubMed ID: 28424222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Clinical Outcomes after Treatment with Excimer Laser Coronary Atherectomy for In-Stent Restenosis of Drug-Eluting Stent.
    Ichimoto E; Kadohira T; Nakayama T; De Gregorio J
    Int Heart J; 2018 Jan; 59(1):14-20. PubMed ID: 29332914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.